Quoin Pharmaceuticals Ltd (QNRX): יחס מחיר להכנסות חזויות

Quoin Pharmaceuticals (QNRX) is focusing its development on clinical trials for treatments targeting rare genetic skin pathologies. The forward price-to-sales valuation illustrates this trend, with the latest reading at . The foundation for growth is exceptional pricing power derived from the patent for the drug QRX-003. Meanwhile, risk is posed by biotech behemoths seeking to acquire promising orphan drug developments to dominate the dermatology sector.
פילוחי מדדים מקיפים ואנליטיקה עבור Quoin Pharmaceuticals Ltd (QNRX)

Forward P/S relates current market capitalization to expected revenue, reflecting the valuation's sensitivity to future cash flow forecasts. For Quoin Pharmaceuticals (QNRX), which is developing a pipeline of drugs for rare dermatoses, this indicator assesses the commercialization potential of QRX-003, allowing the company's forward P/S chart to determine whether the market price is fair relative to sales prospects.